Diagnosis of Whooping Cough by Serology and Real-Time PCR
Authors:
Mikešová Romana; Stiborová Ivana; Richter Josef; Rajnohová Dobiášová Lucie; Král Vlastimil
Published in:
Epidemiol. Mikrobiol. Imunol. 62, 2013, č. 3, s. 106-111
Overview
The goal of this study is to summarize the results of the detection of Bordetella pertussis (BP) and Bordetella parapertussis (BPP) by a real-time polymerase chain reaction (RT-PCR) assay and serological methods. In 2008–2010, 73 patients of the Department of Clinical Immunology and Allergology of the Centre for Immunology and Microbiology, Public Health Institute in Ústí nad Labem were screened for pertussis. They were selected according to the WHO and ECDC criteria, i. e. they presented with a persistent cough lasting more than two weeks.
Direct detection of BP and BPP DNA from nasopharyngeal wash specimens was performed using a RT PCR assay. The serological responses were evaluated by a direct agglutination test for the detection of total antibodies and by enzyme-linked immunosobent assay (ELISA) for the detection of IgG, IgA, and IgM antibodies against pertussis toxin. Forty-two patients were positive for BP and/or BPP, 19 of them by RT-PCR (group A) and 23 by serology (group B). Ten group A patients (52.6%) were also positive by serology.
Our results show that pertussis needs to be a consideration in persistent cough. We believe that increased awareness of the medical community, along with improved laboratory tests will result in increased detection of pertussis that is still considered by many physicians as a childhood infection.
Keywords:
pertusis – persistent cough – whooping cough
Sources
1. André, P., Caro, V., Njamkepo, E., Wendelboe, A. M. et al. Comparison of Serological and Real-Time PCR Assays To Diagnose Bordetella pertussis Infection in 2007. J. Clin. Microbiol., 2008, 46, 5, p. 1672–1677.
2. Bamberger, E. S., Srugo, I. What is new in pertussis? Eur. J. Pediatr., 2008, 167, p. 133–139.
3. Baughman, A. L., Bisgard, K. M., Edwards, K. M., Guris, D. et al. Establishment of Diagnostic Cutoff Points for Level of Serum Antibodies to Pertussis Toxin, Filamentous Hemagglutinin, and Fimbriae in Adolescents and Adults in the United States. Clin. Diagn. Lab. Immunol., 2004, 11, 6, p. 1045–1053.
4. Bidet, P., Liquori, S., De Lauzanne, A., Caro, V. et al. Real--Time PCR Measurement of Persistence of Bordetella pertussis DNA in Nasopharyngeal Secretions during Antibiotic Treatment of Young Children with Pertussis. J. Clin. Microbiol., 2008, 46, 11, p. 3636–3638.
5. Blechová, Z. Opomíjená infekce – pertuse. Pediatr. pro Praxi, 2008, 9, 4, s. 223–226.
6. Caro, V., Guiso, N., Alberti, C., Liguori, S. et al. Proficiency Program for Real-Time PCR Diagnosis of Bordetella pertussis Infection in French Hospital Laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses. J. Clin. Microbiol., 2009, 47, 10, p. 3197–3203.
7. Cassiday, P. K., Tobin-D’Angelo, M., Watson, J. R., Wu, K. H. et al. Co-infection with two different strains of Bordetella pertussis in an infant. J. Med. Microbiol., 2008, 57, p. 388–391.
8. Cornia, P. B., Hersh, A. L., Lipsky, B. A., Newman, T. B. et al. Does This Coughing Adolescent or Adult Patient Have Pertussis? JAMA, 2010, 304, 8, p. 890–896.
9. Dalby, T., Harboe, Z. B., Krogfelt, K. A. Seroprevalence of Pertussis among Danish Patient with Cough of Unknown Etiology. Clin. Vaccine. Immunol., 2010, 17, 12, p. 2016–2033.
10. Fry, N. K., Duncan, J., Wagner, K., Tzivra, O. et al. Role of PCR in the diagnosis of pertussis infection in infants: 5 years´experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J. Med. Microbiol., 2009, 58, p. 1023–1029.
11. Guiso, N., Berbers, G., Fry, N. K., He, Q. et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbial. Infect. Dis., 2011, 30, p. 307–312.
12. Harnden, A., Grant, C., Harrison, T., Perera, R. et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ, 2006, 333, p. 174–177.
13. Harnden, A. Easily Missed?: Whooping cough. BMJ, 2009, 338, p. 1772.
14. Holčíková, A., Štroblová, H., Jirsenská, Z. Může být v diagnostice pertuse přínosné stanovení IgG protilátek k pertusovému toxinu? Klin. Mikrobiol. Inf. Lék., 2006, 12, 5, s. 184–188.
15. Cherry, J. D., Heininger, U., Richards, D. M., Storsaeter, J. et al. Antibody Response Patterns to Bordetella pertussis Antigens in Vaccinated (Primed) and Unvaccinated (Unprimed) Young Children with Pertussis. Clin. Vaccine. Immunol., 2010, 17, 5, p. 741–747.
16. Kösters, K., Riffelmann, M., Dohrn, B., von König, C. H. Comparison of Five Commercial Enzyme-Linked Immunosorbent Assay for Detection of Antibodies to Bordetella pertussis. Clin. Diagn. Lab. Immunol., 2000, 7, 3, p. 422–426.
17. Kříž, B., Fabiánová, K., Maixnerová, M., Beneš, Č. et al. Pertuse – navracející se infekce? Epidemiol. Mikrobiol. Imunol., 2007, 56, 2, s. 51–65.
18. Litt, D. J., Samuel, D., Duncan, J., Harnden, A. et al. Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults. J. Med. Microbiol., 2006, 55, p. 1223–1228.
19. Menzies, S. L., Kadwad, V., Pawloski, L. C., Lin, T. L. et al. Development and Analytical Validation of an Immunoassay for Quantifying Serum Anti-Pertussis Toxin Antibodies Resulting from Bordetella pertussis Infection. Clin. Vaccine. Immunol., 2009, 16, 12, p. 1781–1788.
20. Mertens, P. L., Stals, F. S., Steyerberg, E. W., Richardus, J. H. Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practise. BMC, Infectious Diseases, 2007, 7, p. 53.
21. Poláková, M. Chronický kašel v dětském věku. Problematika pertuse – Disertační práce. Masarykova univerzita – Lékařská fakulta, 2009.
22. Richter, J., Mikešová, R., Stiborová, I., Pohořská, J. et al. Onemocnění dávivým kašlem je časté i v praxi klinického imunologa. Alergie Supplement, 2012, 1, s. 43–46.
23. Stenger, R. M., Smits, M., Kuipers, B., Kessen, S. F. M. et al. Fast, Antigen-Saving Multiplex Immunoassay To Determine Levels and Avidity of Mouse Serum Antibodies to Pertussis, Diphtheria, and Tetanus Antigens. Clin Vaccine Immunol., 2011, 18, 4, p. 595–603.
24. Tozzi, A. E., Celentano, L. P., degli Atti, M. L. C., Salmaso, S. Diagnosis and management of pertussis. CMAJ, 2005, 172, p. 509–515.
25. Turner, S. An asthmatic child with a troublesome cough. BMJ, 2011, 342, p. c6846.
26. Vospělová, J., Zapletalová, J. Stále aktuální pertuse. Pediatr. pro Praxi, 2004, 4, s. 204–206.
27. Watanabe, M., Connelly, B., Weiss, A. A. Characterization of Serological Response to Pertussis. Clin. Vaccine. Immunol., 2006, 13, 3, p. 341–348.
28. Recommended standards for surveillance of selected vaccine-preventable disease. WHO/VB/03.01., 2003, p. 28–30.
29. Vyhláška č. 473/2008 Sb., o systému epidemiologické bdělosti pro vybrané infekce (Příloha č. 3 – Systém epidemiologické bdělosti dávivého kašle), s. 8015–8016.
Labels
Hygiene and epidemiology Medical virology Clinical microbiologyArticle was published in
Epidemiology, Microbiology, Immunology
2013 Issue 3
Most read in this issue
- Diagnosis of Whooping Cough by Serology and Real-Time PCR
- Prevalence of selected congenital anomalies in the Czech Republic: renal and cardiac anomalies and congenital chromosomal aberrations
- Treponema pallidum subspecies pallidum – the Causative Agent of Neurosyphilis
- Dengue Fever Cases in Czech Workers Returning from the Maldives